Does TENAPANOR Cause Product distribution issue? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Product distribution issue have been filed in association with TENAPANOR (IBSRELA). This represents 0.6% of all adverse event reports for TENAPANOR.
11
Reports of Product distribution issue with TENAPANOR
0.6%
of all TENAPANOR reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product distribution issue From TENAPANOR?
Of the 11 reports, 2 (18.2%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENAPANOR. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TENAPANOR Cause?
Diarrhoea (793)
Death (222)
Hospitalisation (138)
Inappropriate schedule of product administration (115)
Off label use (94)
Product use issue (72)
Nausea (59)
Abdominal distension (52)
Therapy interrupted (52)
Abdominal pain (50)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which TENAPANOR Alternatives Have Lower Product distribution issue Risk?
TENAPANOR vs TENECTEPLASE
TENAPANOR vs TENELIGLIPTIN
TENAPANOR vs TENIPOSIDE
TENAPANOR vs TENOFOVIR
TENAPANOR vs TENOFOVIR ALAFENAMIDE